Ben-David, R., Tillu, N., Alerasool, P., Bieber, C., Ranti, D., Tolani, S., Eisenhauer, J., Chung, R., Lavallée, E., Waingankar, N., Attalla, K., Wiklund, P., Mehrazin, R., Anderson, C. B., & Sfakianos, J. P. (2024). Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocols. World Journal of Urology, 42(1). https://doi.org/10.1007/s00345-024-04992-5

Alì, A., Leibowitz, D., Bhatt, N., Doubrovin, M., Spina, C. S., Bates-Pappas, G. E., Taub, R. N., McKiernan, J. M., Mintz, A., & Molotkov, A. (2022). Preliminary efficacy of [90Y]DOTA-biotin-avidin radiotherapy against non-muscle invasive bladder cancer. European Journal of Nuclear Medicine and Molecular Imaging, 50(3), 692–700. https://doi.org/10.1007/s00259-022-06027-w